,title,source,link,date
91,NOT REAL NEWS: A look at what didn't happen this week,CTPost,news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LmN0cG9zdC5jb20vbmV3cy9hcnRpY2xlL25vdC1yZWFsLW5ld3MtYS1sb29rLWF0LXdoYXQtZGlkbi10LWhhcHBlbi10aGlzLTE4MzQyNDc0LnBocNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
64,Ipsen announces change in R&D leadership: Howard Mayer to retire ...,Ipsen,news.google.com/articles/CBMigwFodHRwczovL3d3dy5pcHNlbi5jb20vcHJlc3MtcmVsZWFzZXMvaXBzZW4tYW5ub3VuY2VzLWNoYW5nZS1pbi1yZC1sZWFkZXJzaGlwLWhvd2FyZC1tYXllci10by1yZXRpcmUtc3VjY2VlZGVkLWJ5LWNocmlzdGVsbGUtaHVndWV0L9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
41,"Humira Biosimilar Market Key Players, Industry Overview, Supply ...",Digital Journal,news.google.com/articles/CBMi7wFodHRwczovL3d3dy5kaWdpdGFsam91cm5hbC5jb20vcHIvbmV3cy9jb2hlcmVudC1tYXJrZXQtaW5zaWdodHMvaHVtaXJhLWJpb3NpbWlsYXItbWFya2V0LWtleS1wbGF5ZXJzLWluZHVzdHJ5LW92ZXJ2aWV3LXN1cHBseS1jaGFpbi1hbmQtYW5hbHlzaXMtdG8tMjAyMy0yMDMwLWFtZ2VuLWluYy1zYW1zdW5nLWJpb2VwaXMtY28tbHRkLXNhbmRvei1pbnRlcm5hdGlvbmFsLWdtYmgtbm92YXJ0aXMtYWctbXlsYW4tbi12LdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
48,"Inhalable Drugs Market Global Review Outlook By Application, and By Companies NanoDerma, Pfizer, Aradigm",Benzinga,news.google.com/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vcHJlc3NyZWxlYXNlcy8yMy8wOS8zNDE2NDI5My9pbmhhbGFibGUtZHJ1Z3MtbWFya2V0LWdsb2JhbC1yZXZpZXctb3V0bG9vay1ieS1hcHBsaWNhdGlvbi1hbmQtYnktY29tcGFuaWVzLW5hbm9kZXJtYS1wZml6ZXItYXJhZGnSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzQxNjQyOTM?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
49,IoT Transforming Pharma: Trends & Innovations,Pharmaceutical Technology,news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL2RhdGEtaW5zaWdodHMvaW50ZXJuZXQtb2YtdGhpbmdzLWluLXBoYXJtYS_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
36,New York Businesses: Give Immigrant Work Permits To Asylum Seekers,Forbes,news.google.com/articles/CBMieWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvc3R1YXJ0YW5kZXJzb24vMjAyMy8wOS8wMS9uZXcteW9yay1idXNpbmVzc2VzLWdpdmUtaW1taWdyYW50LXdvcmstcGVybWl0cy10by1hc3lsdW0tc2Vla2Vycy_SAX1odHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL3N0dWFydGFuZGVyc29uLzIwMjMvMDkvMDEvbmV3LXlvcmstYnVzaW5lc3Nlcy1naXZlLWltbWlncmFudC13b3JrLXBlcm1pdHMtdG8tYXN5bHVtLXNlZWtlcnMvYW1wLw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
35,Trial Success Sets Up Roche's Alecensa To Be First ALK+ Drug In ...,Scrip,news.google.com/articles/CBMiggFodHRwczovL3NjcmlwLnBoYXJtYWludGVsbGlnZW5jZS5pbmZvcm1hLmNvbS9TQzE0ODk4Ni9UcmlhbC1TdWNjZXNzLVNldHMtVXAtUm9jaGVzLUFsZWNlbnNhLVRvLUJlLUZpcnN0LUFMSy1EcnVnLUluLUFkanV2YW50LU5TQ0xD0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
58,"In push to boost Kerendia, Bayer adds 3 heart failure trials",FiercePharma,news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JheWVyLWJldHMtYmlnLWtlcmVuZGlhcy1wb3RlbnRpYWwtdHJlYXQtaGVhcnQtZmFpbHVyZdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
27,"Generic API Market Status and Outlook 2023-2029 by Key Players | TEVA Pharmaceuticals , Sun Pharmaceutica",Benzinga,news.google.com/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vcHJlc3NyZWxlYXNlcy8yMy8wOS8zNDE2MjI2Mi9nZW5lcmljLWFwaS1tYXJrZXQtc3RhdHVzLWFuZC1vdXRsb29rLTIwMjMtMjAyOS1ieS1rZXktcGxheWVycy10ZXZhLXBoYXJtYWNldXRpY2Fscy1zdW4tcGhhcm1hY2V1dGnSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzQxNjIyNjI?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
26,"Pituitary Cancer Market Competitive Insights, Significant Futuristic ...",Digital Journal,news.google.com/articles/CBMi1AFodHRwczovL3d3dy5kaWdpdGFsam91cm5hbC5jb20vcHIvbmV3cy9jb2hlcmVudC1tYXJrZXQtaW5zaWdodHMvcGl0dWl0YXJ5LWNhbmNlci1tYXJrZXQtY29tcGV0aXRpdmUtaW5zaWdodHMtc2lnbmlmaWNhbnQtZnV0dXJpc3RpYy10cmVuZHMtYW5kLW9wcG9ydHVuaXRpZXMtMjAzMC1ub3ZhcnRpcy1pbnRlcm5hdGlvbmFsLWFnLXBmaXplci1pbmMtbWVyY2stY28taW5jLdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-01
